Evan J. Worden

1.1k citations
13 papers · 761 indexed · h-index 10
Topics
Ubiquitin and proteasome pathways (8 papers)Epigenetics and DNA Methylation (5 papers)RNA modifications and cancer (4 papers)
Partner nations
United StatesRussiaSpain

In The Last Decade

Evan J. Worden

12 papers receiving 756 citations

Peers

Evan J. Worden
Comparison fields: 5 of 56
  • Molecular Biology 731
  • Cell Biology 166
  • Epidemiology 146
  • Oncology 133
  • Genetics 88
Replace Julius Rabl with:
Julius Rabl Switzerland
Dominik Barthelme United States
Andres H. de la Peña United States
Markus Rohrwild United States
Laura J. Terry United States
Louise C. Briggs United Kingdom
Michael Blau Germany
Galit Kafri Israel
Mekonnen Lemma Dechassa United States
Holly Chamberlin United States
Evan J. Worden relative to Julius Rabl Switzerland Julius Rabl's profile →
Citations per field
00.5×1.5×2.0×
Julius Rabl · 1×
Citations per year

Countries citing papers authored by Evan J. Worden

Since Specialization
Citations

This map shows the geographic impact of Evan J. Worden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan J. Worden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan J. Worden more than expected).

Fields of papers citing papers by Evan J. Worden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan J. Worden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan J. Worden. The network helps show where Evan J. Worden may publish in the future.

Co-authorship network of co-authors of Evan J. Worden

This figure shows the co-authorship network connecting the top 25 collaborators of Evan J. Worden. A scholar is included among the top collaborators of Evan J. Worden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan J. Worden. Evan J. Worden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 9
3 20
4 2
5 71
6 38
7 174
8 73
9 77
10 1
11 125
12 114
13 57

About Evan J. Worden

Evan J. Worden is a scholar working on Molecular Biology, Cell Biology and Genetics, having authored 13 papers that have together received 761 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Molecular Biology (731 citations), Cell Biology (166 citations) and Structural Biology (12 citations). Evan J. Worden has collaborated with scholars based in United States, Russia and Spain. Frequent co-authors include Andreas Martin, Cynthia Wolberger, N. Hoffmann, Eric Estrin, Ken C. Dong, Xiangbin Zhang, Mark A. Herzik, Gabriel C. Lander, Corey M. Dambacher and Bryan A. Krantz. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026